Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
nevtralizacijska vrednost
neutralising value
Last Update: 2017-04-06
Usage Frequency: 2
Quality:
nevtralizacijska protitelesa ne nastajajo pri vseh bolnikih.
neutralising antibodies are not produced in all patients.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
nevtralizacijska sredstva, antioksidanti in sredstva za konzerviranje :
neutralizing agents, antioxidants and preservatives:
Last Update: 2014-11-21
Usage Frequency: 2
Quality:
komponento virusa kpk, proti kateremu so usmerjena nevtralizacijska protitelesa.
the e2 glycoprotein is considered to be the main immunogen of the csf virus against which the neutralising i ed
glikoprotein e2 štejemo za glavno imunogeno komponento virusa kpk, proti kateremu so usmerjena nevtralizacijska protitelesa.
e2, e1, erns, gp54 and gp80.
specifična nevtralizacijska protitelesa proti virusu hepatitisa b so prisotna v koncentraciji, ki znaša najmanj 180 me/ ml.
specific neutralizing antibodies against the hepatitis b virus are present at a concentration of not less than 180 iu/ ml.
podatkov o bolnikih, pri katerih se je razvila nevtralizacijska aktivnost in so dokončali zdravljenje z zdravilom extavia, je malo in so nedokončni.
there are sparse and inconclusive data on patients who have developed neutralising activity and have completed extavia therapy.
bolnike s pozitivnim serumskim izvidom za ne-nevtralizacijska protitelesa so dodatno testirali za nevtralizacijska protitelesa; noben bolnik ni imel pozitivnega izvida za nevtralizacijska protitelesa.
the patients whose sera tested positive for binding antibodies were further evaluated for neutralising antibodies and none of the patients tested positive for neutralising antibodies.
med zdravljenjem z zdravilom betaferon lahko vaše telo izdela snovi, imenovane nevtralizacijska protitelesa, ki lahko reagirajo z zdravilom betaferon (nevtralizacija).
during treatment with betaferon your body may produce substances called neutralising antibodies, which may react with betaferon (neutralising activity).
persistentno pozitivnih (pozitivnih na protitelesa proti vedolizumabu pri dveh ali več študijskih obiskih) je bilo 9 od 56 bolnikov, nevtralizacijska protitelesa proti vedolizumabu pa so se razvila pri 33 bolnikih.
nine out of 56 patients were persistently positive (anti-vedolizumab antibody-positive at two or more study visits) and 33 patients developed neutralizing anti-vedolizumab antibodies.
pri sedmih bolnikih (1,6 %) so se pojavila protitelesa proti tocilizumabu, od teh pri šestih (1,4 %) nevtralizacijska.
seven patients (1.6%) developed positive anti-tocilizumab antibodies; of these, six (1.4%) developed neutralizing anti-tocilizumab antibodies.
občutljivost preizkusa za nevtralizacijska protitelesa in nespecifična protitelesa proti zdravilu (ada – anti-drug antibody) je omejena s prisotnostjo aktivnega zdravila v zbranih vzorcih.
assay sensitivity for neutralising antibodies and non-specific anti-drug antibody (ada) is limited by the presence of active drug in the collected samples.
v kliničnih študijah je imela 0,1 % bolnikov (7 od 4.846 bolnikov s primarno hiperlipidemijo in mešano dislipidemijo ter 0 od 80 bolnikov s homozigotno družinsko hiperholesterolemijo), ki so prejeli vsaj en odmerek zdravila repatha, pozitiven izvid testiranja za ne-nevtralizacijska protitelesa (4 od teh bolnikov so imeli prehodna protitelesa).
in clinical studies, 0.1% of patients (7 out of 4846 patients with primary hyperlipidaemia and mixed dyslipidaemia and 0 out of 80 patients with homozygous familial hypercholesterolaemia) treated with at least one dose of repatha tested positive for binding antibody development (4 of these patients had transient antibodies).